Chan Beals MD PhD
Chief Medical Officer, Abide Therapeutics, San Diego CA
Join to view full profile
Solana CircleSolana Beach, CA 92075
Phone+1 908-839-3395
Dr. Beals is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Pediatric Rheumatology, 1992 - 1995- University of California (San Francisco)Residency, Pediatrics, 1990 - 1992
University of Washington School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1991 - Present
CT State Medical License 2002 - 2023
Clinical Trials
- A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome Start of enrollment: 2017 Feb 01
- Titration Study of ABX-1431 Start of enrollment: 2017 Oct 02
- Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder Start of enrollment: 2018 Oct 15
Publications & Presentations
PubMed
- 5 citationsPatient-reported impact of symptoms in adrenoleukodystrophy (PRISM-ALD).Anika Varma, Jennifer Weinstein, Jamison Seabury, Spencer Rosero, Nuran Dilek
Orphanet Journal of Rare Diseases. 2024-03-19 - 42 citationsNative Oxyntomodulin Has Significant Glucoregulatory Effects Independent of Weight Loss in Obese Humans With and Without Type 2 Diabetes.Sudha S. Shankar, R. Ravi Shankar, Lori A. Mixson, Deborah L. Miller, Barnali Pramanik
Diabetes. 2018-06-01 - 1 citationsInsulin secretory effect of sitagliptin: assessment with a hyperglycemic clamp combined with a meal challengeSudha S. Shankar, R. Ravi Shankar, Lori A. Mixson, Deborah L. Miller, Helmut O. Steinberg
American Journal of Physiology. Endocrinology and Metabolism. 2018-04-01
Press Mentions
- A Pfizer Partner Welcomes Ex-ADC Therapeutics CMO Jay Feingold to the Team; Amid Tough Sledding, Immunovant Chooses Eli Lilly Alum as CFOSeptember 17th, 2021
- Chutes & Ladders—AltruBio Snags New CMO with Resume at Sublimity, Ardea, Amgen and AbbottSeptember 17th, 2021
- Autobahn Therapeutics Strengthens Management Team to Support Advancement of Novel Therapies for CNS DisordersSeptember 14th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
